All IndicationsRare & Genetic Diseases
🧬
Duchenne Muscular Dystrophy (DMD)
1
Companies
1
Drug Programs
0
Phase 3
0
Upcoming PDUFAs
Competitors
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics, Inc. | AVI-4658 (Eteplirsen) | Phase 2 | — | — | — |
Development Stage Distribution
Phase 2
1
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not financial advice
Signals are probabilistic and based on historical data — past performance doesn't guarantee future results. Do your own research.
